Literature DB >> 6817471

Effect of cycloheximide on different stages of Drosophila melanogaster.

R Marcos, J Lloberas, A Creus, N Xamena, O Cabré.   

Abstract

Cycloheximide, an antibiotic inhibiting protein synthesis, exerted a toxic effect on different developmental stages egg, larva and adult of Drosophila melanogaster. At the egg stage the early embryos were most sensitive. With larvae, a strong decrease in viability was found, with no sex difference. In adults, there was a dose-effect relationship, mortality increasing with concentration. At 10 and 15 mM, males were more sensitive than females. There were consistent differences between the control and cycloheximide-fed females in respect of the average number of eggs deposited and offspring produced.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6817471     DOI: 10.1016/0378-4274(82)90145-x

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Transcripts from the Drosophila heat-shock gene hsr-omega influence rates of protein synthesis but hardly affect resistance to heat knockdown.

Authors:  Travis K Johnson; Fiona E Cockerell; Stephen W McKechnie
Journal:  Mol Genet Genomics       Date:  2011-03-12       Impact factor: 3.291

2.  Protein synthesis rates in Drosophila associate with levels of the hsr-omega nuclear transcript.

Authors:  Travis K Johnson; Lauren B Carrington; Rebecca J Hallas; Stephen W McKechnie
Journal:  Cell Stress Chaperones       Date:  2009-03-12       Impact factor: 3.667

3.  Differences between drosophila melanogaster and its sibling species D. simulans in sensitivity to acridine orange treatment.

Authors:  P Alba; M D Ferrés; N Xamena; A Creus; R Marcos
Journal:  Experientia       Date:  1983-03-15

4.  Meep, a Novel Regulator of Insulin Signaling, Supports Development and Insulin Sensitivity via Maintenance of Protein Homeostasis in Drosophila melanogaster.

Authors:  Matthew T Pereira; Katia Brock; Laura Palanker Musselman
Journal:  G3 (Bethesda)       Date:  2020-12-03       Impact factor: 3.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.